Generic in Medical News

While Some New Agents Will Achieve Strong Sales, the Migraine Drug Market Will Decline $1.3 Billion by 2018 as Generic Erosion Takes Toll on Top-Selling Brands

WALTHAM, Mass., Aug. 5 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that although sales of emerging therapies will partially offset losses to generic competitors, the migraine dr...

ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomycin Hydorchloride

EXTON, Pa., Aug. 4 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM ) today announced that the Pharmaceutical Science and Clinical Pharmacology Advisory Committee supports the FDA's Office of Generic Drugs (OGD) draft guidelines on bioequivalence (BE) f...

Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL(R) 25 MG and 50 MG

MORRISTOWN, N.J., Aug. 3 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories, Inc., has received approval today from the United States Food and Drug Administration...

Perrigo Announces FDA Approval for Generic Version of NASACORT(R) AQ

ALLEGAN, Mich., Aug. 3 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO ; TASE) today announced that its partner Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA ) (previously Barr Laboratories Inc.) has received final approval from the U.S. Food and Drug Administration ...

PharmaForce Inc. Receives FDA Approval for First Generic of Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension, USP

COLUMBUS, Ohio, July 31 /PRNewswire/ -- PharmaForce, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension, USP, a ...

Valeant to Acquire Tecnofarma, A Mexican Generic Company

ALISO VIEJO, Calif., July 29 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE: VRX ) announced that it has signed a definitive Sale and Purchase Agreement to acquire Tecnofarma S.A. de C.V., a privately held company located in Mexico for approximately one times sal...

Watson Announces License Agreement With GeneraMedix for Generic Version of Ferrlecit(R)

MORRISTOWN, N.J., July 28 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leader in generic and specialty branded pharmaceuticals, today announced a license agreement with GeneraMedix, Inc., for the exclusive US marketing rights to a generic version of Ferrlecit ...

Mylan Receives FDA Approval for Generic Version of Thyroid Deficiency Treatment Cytomel(R)

PITTSBURGH, July 16 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Liothyronine Sodium Tab...

FDA Accepts Tris Pharma's ANDA with Paragraph IV Certification for a Generic Equivalent to Delsym

SOUTH BRUNSWICK, N.J., July 16 /PRNewswire/ -- Tris Pharma, Inc., a drug delivery and specialty pharmaceutical company, today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 12-hour sust...

Watson Confirms Filing of Abbreviated New Drug Application for Generic Sanctura XR(R)

MORRISTOWN, N.J., July 15 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.-Florida ("Watson"), has filed an Abbreviated New Drug Application (ANDA) with t...

Brazil proves developing countries can use generic medicines to fight HIV/AIDS epidemic

PROVIDENCE, R.I. [Brown University] Brazil's nearly two-decade effort to treat people living with HIV and AIDS shows that developing countries can successfully combat the epidemic. Inexpensive generic medicines are a large part of the solution, say researchers from Brown University and the Harvar...

Watson Pharmaceuticals Receives FDA Approval For Generic PLAN B(R)

MORRISTOWN, N.J., June 24 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories, Inc., has received approval today from the United States Food and Drug Administration on its Abbrev...

Perrigo Confirms That its Partner Synthon Has Filed for Generic Version of Xyzal(R) Solution and Announcement of Lawsuit by Sepracor/UCB

ALLEGAN, Mich., June 24 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO ; TASE) today announced that its partner Synthon Pharmaceuticals, Inc. has filed an Abbreviated New Drug Application (ANDA) for Levocetirizine solution 2.5mg/5ml, a generic version of Xyzal(R) solution 2.5mg/5ml. Und...

Glen's Markets Adds Discounted Generic Drug Program

Now 30-day prescriptions for $4 and 90-day prescriptions for $10 GRAND RAPIDS, Mich., June 19 /PRNewswire/ -- All Glen's Markets pharmacies serving communities throughout northern Michigan are pleased to now offer a generic drug program for 30 day prescriptions for $4 and 90 day prescriptions...

Mylan Receives FDA Approval for Additional Strength of Generic Restoril(R)

Product shipment has begun PITTSBURGH, June 17 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration (FDA) for its supplemental Abbreviated New Drug Application (AND...

Despite Generic Erosion of Key Brands, the Hospital-Acquired Gram Negative Infections Drug Market Will Increase by $1 Billion from 2008 to 2018

Uptake of Novel Agents from Novexel, Johnson & Johnson and Wyeth Will Drive Growth, According to a New Report from Decision Resources WALTHAM, Mass., June 16 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues...

Watson Files FDA Application for Generic Mucinex(R) D

- Paragraph IV Litigation Underway - CORONA, Calif., June 10 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc. - Florida, has filed an Abbreviated New Drug Applicati...

Growth in the Parkinson's Disease Drug Market, Fueled by the Launch of Several New Therapies, Will be Offset by Generic Erosion of Key Agents

Overall Market Will Increase by a Modest $300 Million From 2008 to 2018, According to a New Report from Decision Resources WALTHAM, Mass., June 9 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that gro...

Par Pharmaceutical Begins Shipment of Generic Miacalcin(R)

WOODCLIFF LAKE, N.J., June 9 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX ) today announced that it began shipping calcitonin-salmon nasal spray to the trade. Calcitonin-salmon nasal spray is a generic version of Novartis' Miacalcin (R) . Annual U.S. sales of Miacalc...

More stringent evaluation on the use of generic medications in thoracic transplantation

Philadelphia, 2 June 2009 A closer look at regulatory and clinical concerns with generic immunosuppression medications in thoracic transplantation is required, according to an educational advisory by the International Society for Heart and Lung Transplantation (ISHLT) in the July 2009 issue of Th...

Mylan's Chief Operating Officer Heather Bresch to Testify Before Congress Concerning Patent Settlements Between Brand and Generic Pharmaceutical Companies and Tactics That Delay Market Entry of High Quality, Affordable Generic Drugs

PITTSBURGH, June 1 /PRNewswire-FirstCall/ -- WHAT: Mylan Inc. (Nasdaq: MYL ) has accepted an invitation to testify before the U.S. House of Representatives Judiciary Subcommittee on Courts and Competition Policy at its upcoming hearing: "Pay to Delay: Are Patent Settlements That Delay Ge...

In the Case of Epilepsy, Generic Drugs and Random Product Substitution are Not Always "Good Medicine"

Nisola LLC launches campaign for stricter regulatory approval requirements and continuity of product supply. New York, NY (PRWEB) May 27, 2009 -- A recent report released by Wolters Kluwer Health predicts that by the end of the year, nearly two-thirds of all drug prescr...

National Pharmacy Omnicare Pays 'Unusual' Settlement to Resolve Charges of Generic Drug Switching in Delaware Nursing Homes, Resulting From 'Qui Tam' Lawsuit

Omnicare, Inc., which calls itself "the nation's leading provider of pharmaceutical care for seniors," paid $283,000 to settle Medicaid fraud charges by the State of Delaware. Delaware alleged that the pharmacy had committed Medicaid fraud by illegally switching the drugs of senior cit...

Medtipster, a Search Engine With a National Database of Generic Drugs on Discount Programs That Allows Visitors to Search by Zip Code, by Lowest Price, is Now Out of Beta

TROY, Mich., May 20 /PRNewswire/ -- In an economic environment in which all Americans are trying to save money, and more than 40 million Americans were prevented from filling critical prescriptions due to healthcare costs in 2008 alone, Medtipster was created to offer a solution. Medtipster ...

Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Roxicodone(R) Tablets

DETROIT, May 14 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD ) has recently launched oxycodone hydrochloride tablets on behalf of Sun Pharmaceutical Industries Inc., a subsidiary of Sun Pharmaceutical Industries Ltd. (...

Mail Service and Higher Generic Use Helps Keep Spending in Check, Countering Brand Drug Price Inflation and Specialty Medication Growth

-- Medco reports overall 3.3 percent Drug Trend for 2008 -- Drug Trend managed to a low 1.3 percent excluding specialty medications -- Clients with more than 40 percent mail order experienced a negative drug trend FRANKLIN LAKES, N.J., May 13 /PRNewswire-FirstCall/ -- Brand-name dru...

Mylan Receives Final FDA Approvals for Generic Versions of Anti-Rejection Medication CellCept(R)

PITTSBURGH, May 7 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approvals from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Applications (ANDAs) for Mycophenolate Mofetil Tablets, 500 ...

Webcast Alert: Release of Economic Analysis Revealing $734 Billion in Savings Produced by Using Generic Medicines in 1999 - 2008

ARLINGTON, Va., May 7 /PRNewswire/ -- The Generic Pharmaceutical Association (GPhA) will discuss the results of an independent analysis commissioned from IMS Health, the leading healthcare market intelligence company, revealing that generic pharmaceutical utilization has contributed $734 billion i...

Photos: Generic Pharmaceuticals Saved $734 Billion over Last Decade

Even Greater Savings Would Result from Increasing Funding for FDA, Creating a Workable Pathway for Biogenerics, Expanding Utilization of Generics ARLINGTON, Va., May 7 /PRNewswire/ -- The Generic Pharmaceutical Association (GPhA) today released the results of an independent analysis commi...

DRAXIMAGE(R)'s generic Sestamibi Approved for launch in USA

Exclusive distribution agreement in place with GE Healthcare NOIDA, India, May 4 /PRNewswire/ - Jubilant Organosys Ltd, headquartered in India, announced today that its subsidiary in the United States, DRAXIMAGE LLC has received US Food and Drug Administration (FDA) approval for the Company's...

Lilly Granted Preliminary Injunction to Prevent Launch of Generic Raloxifene

Lilly Continues to Defend Intellectual Property Rights for Evista INDIANAPOLIS, April 22 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY ) announced that the U.S. District Court for the Southern District of Indiana today issued a preliminary injunction to prevent the launch of a ...

Watson Files FDA Applications for Generic Mucinex(R)

- Paragraph IV Litigation Underway - CORONA, Calif., April 22 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading specialty pharmaceutical company, today confirmed that it has filed two Abbreviated New Drug Applications (ANDAs) with the U.S. Food and Drug Administ...

Medical Community Reacts to Obama and Congressional Plans to Approve Generic Forms of Biologic Medicines

National Press Club Event to Highlight Patient Safety and Discuss Policy Recommendations for Moving Forward WASHINGTON, April 16 /PRNewswire-USNewswire/ -- The Obama administration's goal of expanding the availability of generic forms of biologic drugs - and a variety of congressional effor...

Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Topamax(R) Tablets

DETROIT, April 2 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE AMEX: CPD ) has launched Topiramate tablets on behalf of Sun Pharmaceutical Industries Ltd. (Sun Pharma), immediately following Sun Pharma's recently received approval from the US Food and Drug Administrati...

Zydus Pharmaceuticals (USA) Inc. Announces FDA Final Approval for the Generic Version of Topamax(R) Tablets

PRINCETON, N.J., March 27 /PRNewswire/ -- Zydus Pharmaceuticals announced today that it has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Topiramate Tablets USP, 25mg, 50mg, 100mg, and 200mg. This product is available ...

Thomson Reuters Publishes Pharma Matters White Paper, 'The Five Myths of Generic Competition'

Unique Survey Shows Much Room for Originator Pharmaceutical Companies to Improve Their Understanding of Generic Competition PHILADELPHIA and LONDON, March 11 /PRNewswire/ -- The Healthcare and Science business of Thomson Reuters today released the white paper, "The Five Myths of Generic Compe...

Lilly Granted Temporary Restraining Order to Halt Launch of Generic Raloxifene

Lilly Vows to Defend Intellectual Property Rights INDIANAPOLIS, March 9 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY ) today issued the following statement after being granted a temporary restraining order to halt the launch of a generic version of Evista(R) (raloxifene HCl ta...

D&W Fresh Markets, Family Fare and VG's Expand Discounted Generic Drug Program

Now 90-day prescriptions for $10 - Plus More Women's Health Medications GRAND RAPIDS, Mich., March 2 /PRNewswire/ -- Starting March 1, 2009, D&W Fresh Market, Family Fare and VG's pharmacies will expand their generic drug program to 90-day prescriptions for only $10 - now there are two pr...

Wal-Mart's $4 Generic Prescription Drug List Added to Epocrates' Drug Reference Application

Prescribers Now Have Access to Low-Price Generic Options, Helping Consumers Save Money on Prescriptions BENTONVILLE, Ark., Feb. 19 /PRNewswire-FirstCall/ -- Wal-Mart Stores Inc. (WMT) today announced its list of up to 350 prescriptions on its $4 generic drug program will now be accessible to ...

Mylan Receives FDA Approval for First-to-File Generic Depakote(R) ER

Company will have 180 days of marketing exclusivity on the 500 mg strength PITTSBURGH, Jan. 30 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbrev...